Literature DB >> 26562147

Family planning as a critical component of sustainable global development.

Babatunde Osotimehin1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26562147      PMCID: PMC4642356          DOI: 10.3402/gha.v8.29978

Source DB:  PubMed          Journal:  Glob Health Action        ISSN: 1654-9880            Impact factor:   2.640


× No keyword cloud information.
In September 2015, under the leadership of United Nations Secretary-General Ban Ki-Moon, the international community took a huge step forward for people, the planet, and prosperity with the adoption of the 2030 Agenda for Sustainable Development. The 17 Sustainable Development Goals (SDGs) pave a brave path towards a world of equity and inclusion, health, including sexual and reproductive health and reproductive rights, education, and greater equality (1). Over the 1990–2015 timeframe of the Millennium Development Goals and, particularly since the 1994 International Conference on Population and Development, considerable progress has been made in women's sexual and reproductive health, including increases in contraceptive use globally, expanded access to skilled maternity care, and the reduction of new HIV infections and maternal and newborn deaths. The secretary-general's ‘Every Woman Every Child’ strategy (2) has catalysed increased leadership and commitment from governments and strong support from all partners, including United Nations agencies, non-governmental organisations, foundations, academia and professional associations. Behind the positive global trends, however, lie significant differences among and within countries. For example, around 225 million women in low- and middle-income countries (LMICs) who do not want to become pregnant are not using modern contraception. It is estimated that 30 million unplanned births and 40 million abortions, half of them illegal and unsafe, occur annually. An estimated 499 million new sexually transmitted infections (excluding HIV) occur annually, approximately half among girls and women (2, 3). The papers in this Special Issue reinforce the centrality of universal access to modern contraception within the SDGs and targets set for 2030 (1). Indeed the research and findings presented here point to an ecological correlation between satisfying demand for family planning using modern contraceptives and economic development (4). To reach the proposed benchmark of 75%, demand satisfied with modern methods of contraception would need to increase by 2.2 percentage points annually between 2014 and 2030 – more than double the current projections on average across the 63 countries analysed. Such rapid progress would require significant effort, particularly to meet needs among adolescent girls. If the 75% benchmark were achieved, 334 million women across the LMICs studied would use a modern contraceptive method by 2030, compared to 226 million women in 2014. Strategies to increase family planning coverage (FPC) have to be backed up by effective metrics for assessing progress. For this purpose, a new FPC indicator has been developed by the authors in this special issue, based on the prevalence of contraceptive use (5). Although coverage is an important indicator, meeting unmet needs and ensuring universal access to human rights-based family planning will not be achieved without addressing equity and quality issues. In this Special Issue, some authors have taken a detailed look at differences in access and use at the subnational level and over time in three countries: Burkina Faso, Ethiopia, and Nigeria (6–8). In all three cases they discovered substantial variations in modern contraceptive use between rural and urban areas and by other socio-economic factors. Consistently across all three countries the results confirm an association between fertility history and modern contraceptive use, as well as between low modern contraceptive use and higher birth risks, leading to increased child mortality. Moreover, women living in rural areas have significantly higher odds of avoidable birth risks (and hence child mortality) compared to their counterparts living in urban areas. In Burkina Faso short birth spacing ranked as the highest risk in relation to child deaths (6). As the world aspires to a situation in which every adolescent girl and woman has easy access to comprehensive sexuality education and contraceptive services, studies here on contraceptive use among sexually active adolescents in Burkina Faso, Ethiopia, and Nigeria (9) and postpartum family planning uptake in Ethiopia, Malawi, and Nigeria (10) also highlighted equity and quality issues. Health systems must address these issues as the global community moves towards universal access. Marriage at very young ages is not only a human rights issue in itself, but also a barrier to modern contraceptive use, and it thus disempowers girls. Adolescent girls experience significant inequality in access to modern contraception by education, residence, and wealth quintile. The results from Ethiopia, however, show that leadership and commitment at the country level can bring change. The authors reported a significant and systematic reduction of inequalities, but also a narrowing of the equity gap, most notably for childbearing adolescents with no education or living in rural areas. Mortality risks associated with low birth spacing have been further studied to assess potential confounding in the association between short-birth intervals and increased neonatal, infant, and child mortality in order to better inform attributable effects (11). After adjusting for confounding, the authors reported that neonatal, infant, and child mortality remained strongly and significantly related to short birth intervals, albeit with a one third reduction in the attributable risk ratio. Any resilient health system must take into account the provision of reproductive, maternal, newborn, and adolescent health services across the life cycle, including easy access to family planning. The findings in these papers point to missed opportunities for integrating maternal and newborn health, including failure to combine child immunisation with family planning, as the factor most associated with the non-uptake of modern contraception in the postpartum period (10). As we celebrate the historic adoption of the SDGs and look ahead to their implementation, access to family planning represents an important entry point and a marker for universal access to reproductive health and rights. Access to modern contraception reduces the risks of maternal and newborn deaths (11) as well as reducing lifetime parity, and thus it affects health, life expectancy, and the dependency ratio. The availability of family planning affects education prospects and human capital among adolescent girls by preventing teenage pregnancies and enabling girls to stay in school. It could also improve access to food and reduce hunger by reducing the dependency ratio. Urbanisation and population dynamics are intrinsically linked, particularly internal and external migration, which have poverty as a root cause. Access to modern contraception can spur the economy, protect the environment, and contribute to overall poverty reduction. The research findings in this Special Issue, which come from distinguished scientists in United Nations agencies, non-governmental organisations, and universities, present a range of global and local policy and programmatic priorities to address measurement, coverage, impact, quality and equity issues in family planning services, which are integral to the global sustainable development agenda. This is particularly important for countries in sub-Saharan Africa. We thus call on world leaders and financiers to join forces and work towards the future we want, a future in which every pregnancy is wanted, every birth is safe, and every young person's potential is fulfilled.
  9 in total

Review 1.  Towards a new Global Strategy for Women's, Children's and Adolescents' Health.

Authors:  Marleen Temmerman; Rajat Khosla; Zulfiqar A Bhutta; Flavia Bustreo
Journal:  BMJ       Date:  2015-09-14

2.  Patterns and trends of contraceptive use among sexually active adolescents in Burkina Faso, Ethiopia, and Nigeria: evidence from cross-sectional studies.

Authors:  Sennen Hounton; Aluisio J D Barros; Agbessi Amouzou; Solomon Shiferaw; Abdoulaye Maïga; Akanni Akinyemi; Howard Friedman; Desmond Koroma
Journal:  Glob Health Action       Date:  2015-11-09       Impact factor: 2.640

3.  Potential confounding in the association between short birth intervals and increased neonatal, infant, and child mortality.

Authors:  Jamie Perin; Neff Walker
Journal:  Glob Health Action       Date:  2015-11-09       Impact factor: 2.640

4.  Trends and patterns of modern contraceptive use and relationships with high-risk births and child mortality in Burkina Faso.

Authors:  Abdoulaye Maïga; Sennen Hounton; Agbessi Amouzou; Akanni Akinyemi; Solomon Shiferaw; Banza Baya; Dalomi Bahan; Aluisio J D Barros; Neff Walker; Howard Friedman
Journal:  Glob Health Action       Date:  2015-11-09       Impact factor: 2.640

5.  Estimating family planning coverage from contraceptive prevalence using national household surveys.

Authors:  Aluisio J D Barros; Ties Boerma; Ahmad R Hosseinpoor; María C Restrepo-Méndez; Kerry L M Wong; Cesar G Victora
Journal:  Glob Health Action       Date:  2015-11-09       Impact factor: 2.640

6.  Patterns and trends of postpartum family planning in Ethiopia, Malawi, and Nigeria: evidence of missed opportunities for integration.

Authors:  Sennen Hounton; William Winfrey; Aluisio J D Barros; Ian Askew
Journal:  Glob Health Action       Date:  2015-11-09       Impact factor: 2.640

7.  Trends in contraceptive use and distribution of births with demographic risk factors in Ethiopia: a sub-national analysis.

Authors:  Solomon Shiferaw; Muna Abdullah; Yared Mekonnen; Abdoulaye Maïga; Akanni Akinyemi; Agbessi Amouzou; Howard Friedman; Aluisio J D Barros; Sennen Hounton
Journal:  Glob Health Action       Date:  2015-11-09       Impact factor: 2.640

8.  Meeting demand for family planning within a generation: prospects and implications at country level.

Authors:  Yoonjoung Choi; Madeleine Short Fabic; Sennen Hounton; Desmond Koroma
Journal:  Glob Health Action       Date:  2015-11-09       Impact factor: 2.640

9.  Contraceptive use and distribution of high-risk births in Nigeria: a sub-national analysis.

Authors:  Akanni Akinyemi; Sunday Adedini; Sennen Hounton; Ambrose Akinlo; Olanike Adedeji; Osarenti Adonri; Howard Friedman; Solomon Shiferaw; Abdoulaye Maïga; Agbessi Amouzou; Aluisio J D Barros
Journal:  Glob Health Action       Date:  2015-11-09       Impact factor: 2.640

  9 in total
  10 in total

1.  Community-based integrated approach to changing women's family planning behaviour in Pakistan, 2014-2016.

Authors:  H Najmi; H Ahmed; G M Halepota; R Fatima; M Ul Haq; A Yaqoob; A Latif; W Ahmad; A Khursheed
Journal:  Public Health Action       Date:  2018-06-21

2.  Determinants of modern contraceptive utilization among married women in sub-Saharan Africa: multilevel analysis using recent demographic and health survey.

Authors:  Zemenu Tadesse Tesema; Getayeneh Antehunegn Tesema; Moges Muluneh Boke; Temesgen Yihunie Akalu
Journal:  BMC Womens Health       Date:  2022-05-18       Impact factor: 2.742

3.  Patient-Planetary Health Co-benefit Prescribing: Emerging Considerations for Health Policy and Health Professional Practice.

Authors:  Nicole Redvers
Journal:  Front Public Health       Date:  2021-04-30

4.  Pattern and determinants of contraceptive usage among women of reproductive age from the Digo community residing in Kwale, Kenya: results from a cross-sectional household survey.

Authors:  Vernon Mochache; Amyn Lakhani; Hajara El-Busaidy; Marleen Temmerman; Peter Gichangi
Journal:  BMC Womens Health       Date:  2018-01-08       Impact factor: 2.809

5.  Quality of care in family planning services in rural Mozambique with a focus on long acting reversible contraceptives: a cross-sectional survey.

Authors:  Anna Galle; Heleen Vermandere; Sally Griffin; Málica de Melo; Lino Machaieie; Dirk Van Braeckel; Olivier Degomme
Journal:  BMC Womens Health       Date:  2018-12-12       Impact factor: 2.809

6.  Trends in contraceptive prevalence rates in sub-Saharan Africa since the 2012 London Summit on Family Planning: results from repeated cross-sectional surveys.

Authors:  Saifuddin Ahmed; Yoonjoung Choi; Jose G Rimon; Souleymane Alzouma; Peter Gichangi; Georges Guiella; Patrick Kayembe; Simon P Kibira; Fredrick Makumbi; Funmilola OlaOlorun; Elizabeth Omoluabi; Easmon Otupiri; Sani Oumarou; Assefa Seme; Solomon Shiferaw; Philip Anglewicz; Scott Radloff; Amy Tsui
Journal:  Lancet Glob Health       Date:  2019-05-17       Impact factor: 26.763

7.  Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa.

Authors:  Jennifer A Smith; Leo Beacroft; Fareed Abdullah; Buyile Buthelezi; Manala Makua; Chelsea Morroni; Gita Ramjee; Claudia Velasquez; Timothy B Hallett
Journal:  J Int AIDS Soc       Date:  2020-10       Impact factor: 5.396

8.  Multilevel analysis of the role of women's empowerment on use of contraceptive methods among married Cambodian women: evidence from demographic health surveys between 2005 and 2014.

Authors:  Owen Nkoka; Daphne Lee; Kun-Yang Chuang; Ying-Chih Chuang
Journal:  BMC Womens Health       Date:  2021-01-06       Impact factor: 2.809

9.  Utilization of Long-Acting Reversible Contraceptives and Associated Factors Among Reproductive Age Women Attending Governmental Health Institutions for Family Planning Services in Wondo Genet District, Sidama, National Regional State, Southern Ethiopia.

Authors:  Amelo Bolka Gujo; Assefa Philipos Kare
Journal:  Health Serv Res Manag Epidemiol       Date:  2021-03-17

10.  Use of modern contraceptives among married women in Vietnam: a multilevel analysis using the Multiple Indicator Cluster Survey (2011) and the Vietnam Population and Housing Census (2009).

Authors:  Lan Thi Hoang Vu; Juhwan Oh; Quyen Thi-Tu Bui; Anh Thi-Kim Le
Journal:  Glob Health Action       Date:  2016-02-29       Impact factor: 2.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.